After a Rocky Start, Novavax Vaccine Could Be Here by Summer

Even with two other vaccines authorized, Novavax is having no trouble recruiting volunteers for its U.S. trial. If all goes well, the U.S. could see 110 million doses in June.

By KATIE THOMAS | NYTimes Health | Disclosure